Calendar

pharmadog

Week of Oct 20, 2025

Oct 24, 2025approval296d agoNEFFY (EPINEPHRINE) — FDA approvalInternational Medication Systems Ltd

Sponsor: ARS PHARMS OPERATION. Form: SPRAY. Route: NASAL

full page →fda approvals ↗

Oct 24, 2025approval296d agoWINREVAIR (SOTATERCEPT-CSRK) — FDA approvalsotatercept

Sponsor: MERCK SHARP DOHME. Form: INJECTABLE. Route: INJECTION

full page →sotatercept →fda approvals ↗

Oct 24, 2025approval296d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL

full page →tramadol hydrochloride ER →fda approvals ↗

Oct 24, 2025approval296d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

full page →acetaminophen ER →fda approvals ↗

Oct 24, 2025approval296d agoTRAMADOL HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 24, 2025approval296d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

full page →acetaminophen ER →fda approvals ↗

Oct 24, 2025approval296d agoATROPINE SULFATE — FDA approvalATROPINE SULFATE

Sponsor: HIKMA. Form: SOLUTION. Route: INTRAVENOUS

full page →ATROPINE SULFATE →fda approvals ↗

Oct 24, 2025approval296d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL

full page →ALDACTAZIDE →fda approvals ↗

Oct 24, 2025approval296d agoANASTROZOLE — FDA approvalStason Pharmaceuticals Inc

Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 24, 2025approval296d agoLEFLUNOMIDE — FDA approvalLEFLUNOMIDE

Sponsor: HERITAGE. Form: TABLET. Route: ORAL

full page →LEFLUNOMIDE →fda approvals ↗

Oct 24, 2025approval296d agoSYNJARDY XR (EMPAGLIFLOZIN) — FDA approval(empagliflozin + metformin hydrochloride ER)

Sponsor: BOEHRINGER INGELHEIM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →(empagliflozin + metformin hydrochloride ER) →fda approvals ↗

Oct 24, 2025approval296d agoLYNKUET (ELINZANETANT) — FDA approvalBayer USA LLC

Sponsor: BAYER HLTHCARE. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Oct 24, 2025approval296d agoREVUFORJ (REVUMENIB CITRATE) — FDA approvalrevumenib citrate

Sponsor: SYNDAX. Form: TABLET. Route: ORAL

full page →revumenib citrate →fda approvals ↗

Oct 24, 2025approval296d agoCOPIKTRA (DUVELISIB) — FDA approvalSecura Bio Inc

Sponsor: SECURA. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Oct 24, 2025approval296d agoGLYXAMBI (EMPAGLIFLOZIN) — FDA approval(empagliflozin + linagliptin)

Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

full page →(empagliflozin + linagliptin) →fda approvals ↗

Oct 24, 2025approval296d agoLETROZOLE — FDA approvalHikma Pharmaceuticals Plc

Sponsor: HIKMA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 24, 2025approval296d agoANASTROZOLE — FDA approvalANASTROZOLE

Sponsor: SANDOZ. Form: TABLET. Route: ORAL

full page →ANASTROZOLE →fda approvals ↗

Oct 24, 2025approval296d agoSYNJARDY (EMPAGLIFLOZIN) — FDA approvalSYNJARDY

Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

full page →SYNJARDY →fda approvals ↗

Oct 24, 2025approval296d agoTRIJARDY XR (EMPAGLIFLOZIN) — FDA approval(empagliflozin + linagliptin + metformin hydrochloride) ER

Sponsor: BOEHRINGER INGELHEIM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →(empagliflozin + linagliptin + metformin hydrochloride) ER →fda approvals ↗

Oct 24, 2025approval296d agoROCURONIUM BROMIDE — FDA approvalROCURONIUM BROMIDE

Sponsor: B BRAUN MEDICAL. Form: SOLUTION. Route: INTRAVENOUS

full page →ROCURONIUM BROMIDE →fda approvals ↗

Oct 24, 2025approval296d agoJARDIANCE (EMPAGLIFLOZIN) — FDA approvalSYNJARDY

Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL

full page →SYNJARDY →fda approvals ↗

Oct 24, 2025approval296d agoNEOSTIGMINE METHYLSULFATE — FDA approvalNEOSTIGMINE METHYLSULFATE

Sponsor: AMPHASTAR PHARMS INC. Form: SOLUTION. Route: INTRAVENOUS

full page →NEOSTIGMINE METHYLSULFATE →fda approvals ↗

Oct 24, 2025approval296d agoRIVAROXABAN — FDA approvalRIVAROXABAN

Sponsor: MSN. Form: TABLET. Route: ORAL

full page →RIVAROXABAN →fda approvals ↗

Oct 24, 2025approval296d agoANASTROZOLE — FDA approvalANASTROZOLE

Sponsor: HIKMA. Form: TABLET. Route: ORAL

full page →ANASTROZOLE →fda approvals ↗

Oct 25, 2025approval295d agoCARBON DIOXIDE, USP (CARBON DIOXIDE) — FDA approval

Sponsor: ROBERTS OXYGEN CO INC. Form: GAS. Route: INHALATION

full page →fda approvals ↗

Week of Oct 27, 2025

Oct 27, 2025approval293d agoTRAMADOL HYDROCHLORIDE — FDA approvalTrigen Laboratories Inc

Sponsor: PLIVA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Oct 27, 2025approval

← prev

page 1 of 43

Week of Oct 20, 2025

Week of Oct 27, 2025